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INTRODUCTION 
Scrapie, a disease of sheep, was well known in the eighteenth century,' but 
despite a long period of study, the etiologic agent has not been clearly identified, al- 
though it is generally considered to be a virus disease.* Observations of scrapie in 
sheep and laboratory animals indicate that it is an irreversibly fatal disease.' 
Katz and Koprowski3 and Worthington' indicated that scrapie neither stimulated 
nor altered the response of mice to interferon inducers. Also, neither exogenous in- 
terferon6*" nor the interferon inducers ~ t a t o l o n , ~  polyinosinic-polycytidylic acid 
[poly(I:C)],* and Newcastle disease virus' were able to alter the courseof the disease 
in mice when administered peripherally. 
Interferon inducers generally have a striking effect on viral diseases of the central 
nervous system other than scrapie. M5-8450, a statolon predecessor, given pe- 
ripherally, was effective against poliovirus infection initiated peripherally, but not in- 
t ra~erebra l ly .~  However, M5-8450 was quite effective against intracerebrally inocu- 
lated virus when administered by the same route.8 Similarly, pretreatment with in- 
terferon inducers intracerebrally was more effective than intraperitoneal treatment 
in preventing vaccinia1 encephalitis in mice.9 The latter study suggested that once a 
virus reached the brain, peripheral treatment with exogenous interferon or inducers 
had little effect on progression of the disease. 
Since the technique of direct intracerebral treatment had been effective against 
other virus diseases of the central nervous system, the present study was undertaken 
to determine its effectiveness in scrapie. 
METHODS 
Animals. Laboratory-bred female Swiss-Webster mice weighing 15-20 g were 
used in these studies. 
Interferon Inducers. Poly(1:C) was purchased from Microbiological Associates, 
Bethesda, Md., as a solution containing 1 mg/ml. Statolon was supplied by Dr. W. J. 
Kleinschmidt, Lilly Research Laboratories, Indianapolis, Ind. Sendai virus, provided 
by Professor Minuse of this laboratory, was used as allantoic fluid containing 512 
hemagglutination (HA) units/ml. 
*Supported by U. S. Public Health Service Training Grant 5 T l A l  00060 from the National 
Institute of Allergy and Infectious Diseases. Present address: ICN Pharmaceuticals, Inc., Nu- 
cleic Acid Research Institute, Irvine, Calif. 92715. Part of this material is from a dissertation 
submitted in partial fulfillment of requirements for the degree of Doctor of Philosophy, 
Rackham School of Graduate Studies, University of Michigan. 
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TABLE I 
SURVIVAL TIMES OF MICE TREATED INTRACEREBRALLY WITH INTERFERON INDUCERS 24 HR 
PRIOR TO INTRACEREBRAL SCRAPlE AGENT 1NOCULATlON 
Mean Survival Survival 
Time Range Difference Difference 
Survival Time Time 
Inducer Dose (days) (days) (days) P* 
Saline 0.03 ml 158.2 132-169 
Statolon 45 Pg 149.5 129- I70 8.7 >0.05 
Saline 0.03 ml 162.1 148 -183 
Poly( 1:C) 0.3 Pg I55 134-170 7. I >0.05 
30.0 pg 154.8 142-175 7.3 >0.05 
Saline 0.03 ml 162.1 148-183 
Sendai 1.5 HA 144.8 129-156 17.3 <0.01 
virus units 
*Probability determined by t-test. 
Scrupie Agent. The Chandler strain of mouse-adapted scrapie agent, provided by 
Dr. W. J. Hadlow, was used as a 1 %  saline suspension of the sixth mouse brain 
passage. 
Experimental Method. Groups of 20 mice were infected by intracerebral inocula- 
tion of LD,, of scrapie agent. The disease was evaluated by determining the 
mean survival times and by following the alteration of the hindleg responses of mice 
as described previously.'0 Animals were observed daily for deaths and weekly for 
hindleg responses. To compare the disease development in different groups, 
differences in mean survival times and mean disease scores were evaluated using the 
t-test. Only animals dying after termination of treatment were used to calculate the 
mean survival times. Interferon inducers were administered intracerebrally in 
volumes of 0.03 ml starting 24 hr before infection. Poly(1:C) was injected weekly for 8 
weeks following infection. Statolon and Sendai were given biweekly for 6 and 5 
weeks, respectively. 
TABLE 2 
S U R V I V A L  TIMES OF MICE RECEIVING MULTIPLE INTRACEREBRAL TREATMENTS WKH 
INTERFERON INDUCERS STARTING 24 HR PRIOR TO INTRACEREBRAL SCRAPlE AGENT 
INOCULATION 
Mean Survival Survival 
Time Range Difference Difference 
Survival Time Time 
Inducer Dose Interval (days) (days) (days) P* 
Statolon 45 pg x 7 biweekly 128.3 97-161 18.5 <O.OOl 
Saline 0.03 ml x 7 biweekly 146.8 121-176 
Saline 0.03 ml x 9 weekly 150.3 139- I60 
Poly(l:C) 0.3 pg x 9 weekly 153.0 140-163 2.7 >0.05 
30.0 pg x 9 weekly 136.8 83-166 13.5 >0.05 
Saline 0.03 ml x 6 biweekly 153.6 128- 165 
Sendai 1.5 HA biweekly 131.9 117-148 21.7 <O.OOl 
virus units x 6 
*Probability determined by t-test. 
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FIGURE 1. Acceleration of scrapie by poly(1:C); doses specified given intracerebrally once 
weekly for nine weeks, starting day before infection. 0,  Saline control: A, 30 pg poly(1:C); m, 0.3 
Pg POly(l:C). 
RESULTS 
A single intracerebral pretreatment with interferon inducers shortened the life 
span of scrapie-infected mice by 7.1 to 17.3 days (TABLE l ) ,  although the only inducer 
that produced a significant lowering of survival time was Sendai virus. When multiple 
intracerebral treatments were given, only one material, the low poly(1:C) dose, failed 
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FIGURE 2. Acceleration of scrapie by statolon, given intracerebrally biweekly seven times, 
starting the day before infection. 0,  Saline control; A, 45 pg statolon. 
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to shorten the life span of treated mice (TABLE 2 ) .  Statolon, Sendai, and the high dose 
of poly(1:C) shortened mean survival times by 13.5 to 21.7 days. The decrease seen 
with statolon and Sendai was significant. Four animals in the high-dose poly(1:C) 
group, showing signs of advanced disease, died during the treatment period; 
therefore, the mean survival time shown in TABLE 2 does not show the full extent off 
acceleration seen in this group. Although the high dose of poly(1:C) shortened the 
mean survival time by 13.5 days, variation within the group prevented this from being 
a significant difference. Multiple treatments (TABLE 2) that hastened death also ac- 
celerated the progression to all stages of the disease (FIGURES 1-3). 
Uninfected animals treated with saline or interferon inducers remained normal 
for a period of I 1  months. 
Days following infection 
a .Z 0.05 
b<0 .01  
C ~ O . 0 0 1  
FIGURE 3. Acceleration o f  scrapie by Sendai virus, given intracerebrally biweekly six times 
starting the day before infection. 0,  Saline control; A, 1.5 HA units Sendai virus. 
DISCUSSION 
Single intracerebral treatments with interferon inducers prior to scrapie infection 
hastened the death of treated mice. Of the inducers tested, however, only Sendai 
virus significantly reduced the mean survival time of treated mice. 
Multiple treatments with 0.3 pg poly(1:C) produced a nonsignificant 2.7 day 
increase in survival time. Multiple doses of 30 l g  poly(1:C) and the other inducers 
produced greater acceleration of death than the single treatments. 
Of the inducers tested, Sendai virus produced the greatest acceleration of death 
in treated mice. Although not lethal when injected intracerebrally, it does replicate in 
mice and can cause death following intranasal instillation. Cell membranes are  the 
major sites of replication of Sendai and the scrapie agent. Therefore, Sendai may 
enhance the effect of  scrapie by alterating cell membranes. 
None of the inducers produced apparent adverse effects in  toxicity control mice. 
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Nevertheless, it is possible that the repeated instillation of a foreign substance into 
the brain after scrapie infection might accelerate disease by an irritating effect. 
Interferon inducers have been shown to stimulate resistance mechanisms other 
than interferon induction. Among these is a stimulation of the reticuloendothelial 
system by poly(1:C) and endotoxin.'1*'2 Also, virus-induced interferon was found to 
stimulate phagocytosis by mouse mononuclear cells.I3 Acceleration of scrapie by in- 
terferon inducers may result from stimulation of lymphoid cells, which are believed 
to be important in the pathogenesis of scrapie.I4*l5 
This study demonstrates that the course of scrapie can be altered. Even though 
the effect was disease enhancement, the ability to manipulate the disease may 
contribute to understanding the nature of the agent and the pathogenesis of the 
disease. Although the acceleration of disease by the interferon inducers tested may 
have been quite specific for scrapie, this work suggests an area for vigilance in the 
clinical development of interferon inducers, the possibility of enhancing or inciting a 
human slow disease. 
SUMMARY 
lnterferon inducers were used in the target-organ treatment of scrapie in mice. 
Intracerebral treatments began 24 hr prior to intracerebral inoculation of LD,, 
of the Chandler strain of scrapie agent. The treatments included 30 and 0.3 pg 
poly(1:C) given weekly 9 times, 45 pg statolon given biweekly 7 times, or 1.5 H A  units 
of Sendai virus given biweekly 6 times. All treatments except the lower dose of 
poly(1:C) accelerated death in scrapie-affected mice. Compared to saline-treated 
control groups, 30 pg poly(I:C), given weekly, shortened the mean survival time 13.5 
days. Groups treated with statolon or Sendai virus had their mean survival times 
shortened 18.5 and 21.7 days, respectively. Infected mice were also evaluated for 
signs of disease at  approximately weekly intervals using a numerical scoring method. 
Acceleration was also apparent using this parameter of disease. When treatment oc- 
curred only once, Sendai virus was the only inducer to significantly shorten the sur- 
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